THURSDAY, Oct. 15 -- Researchers have identified a potential target for drug treatment of spinal cord injuries.

Cells in spinal cord scar tissue release molecules that prevent severed nerve fibers from passing the damaged area and making new connections that would restore feeling and movement.

In the new study, researchers identified where these molecules -- chondroitin sulfate proteoglycans (CSPGs) -- bind to the surface of neurons. This location may offer a target for drug therapy.

More on: